Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 8, 2013, after the close
10-Q filed Aug 8, 2013, 39 days after period end · 0001144204-13-043952
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $2.50K | $78.13K | $0.00 | — |
| Net Income | -$6.25M | -$2.38M | -$3.65M | -$4.95M |
| EPS Diluted | -$0.09 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.08 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
